Macular degeneration focused firm eyes the clinic after series B

Character Biosciences raises $93 million to advance its peptide-based eye disease treatments

Mar 25, 2025 - 14:13
 0
Macular degeneration focused firm eyes the clinic after series B
Character Biosciences raises $93 million to advance its peptide-based eye disease treatments